APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plasma Albumin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Plasma Albumin Industry Growth and Trends Forecast to 2032

2 January 2026119 pages

Choose your research edition.

Industry ResearchPlasma Albumin Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Albumin Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Plasma Albumin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Albumin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Albumin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Plasma Albumin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Plasma Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Plasma Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Plasma Albumin include Yuanda Shuyang, Takeda, Weiguang Bio, Tiantan Bio, Shanghai RAAS, Hualan Bio, Shuanglin Bio, Octapharma and LFB Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Plasma Albumin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Plasma Albumin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasma Albumin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasma Albumin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Plasma Albumin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Plasma Albumin Market by Company

Yuanda Shuyang

Takeda

Weiguang Bio

Tiantan Bio

Shanghai RAAS

Hualan Bio

Shuanglin Bio

Octapharma

LFB Group

Kedrion

Grifols

CSL

CBPO

Boya Bio

Biotest

Plasma Albumin Segment by Type

20-25% Concentrations

5% Concentrations

Plasma Albumin Segment by Application

Therapeutics

Excipient

Other

Plasma Albumin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Albumin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plasma Albumin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Plasma Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 20-25% Concentrations Table 2. Major Company of 5% Concentrations Table 3. Global Plasma Albumin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Plasma Albumin Sales by Type (2021-2026) & (K Units) Table 5. Global Plasma Albumin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Plasma Albumin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Plasma Albumin Sales Market Share in Value by Type (2021-2026) Table 8. Global Plasma Albumin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Plasma Albumin Sales by Type (2027-2032) & (K Units) Table 10. Global Plasma Albumin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Plasma Albumin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Plasma Albumin Sales Market Share in Value by Type (2027-2032) Table 13. Global Plasma Albumin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Plasma Albumin Sales by Type (2021-2026) & (K Units) Table 15. North America Plasma Albumin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Plasma Albumin Sales by Type (2021-2026) & (K Units) Table 17. Europe Plasma Albumin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Plasma Albumin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Plasma Albumin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Plasma Albumin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Plasma Albumin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Plasma Albumin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Plasma Albumin Sales by Type (2021-2026) & (US$ Million) Table 24. Plasma Albumin Industry Trends Table 25. Plasma Albumin Industry Drivers Table 26. Plasma Albumin Industry Opportunities and Challenges Table 27. Plasma Albumin Industry Restraints Table 28. Global Plasma Albumin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Plasma Albumin Revenue Market Share by Company (2021-2026) Table 30. Global Plasma Albumin Sales by Company (2021-2026) & (K Units) Table 31. Global Plasma Albumin Sales Share by Company (2021-2026) Table 32. Global Plasma Albumin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Plasma Albumin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Plasma Albumin Major Company Production Sites and Headquarters Table 35. Global Plasma Albumin Company, Product Type & Application Table 36. Global Plasma Albumin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Plasma Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Plasma Albumin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Plasma Albumin Sales by Region (2021-2026) & (K Units) Table 41. Global Plasma Albumin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Plasma Albumin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Plasma Albumin Sales Market Share in Value by Region (2021-2026) Table 44. Global Plasma Albumin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Plasma Albumin Sales by Region (2027-2032) & (K Units) Table 46. Global Plasma Albumin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Plasma Albumin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Plasma Albumin Sales Market Share in Value by Region (2027-2032) Table 49. Global Plasma Albumin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Plasma Albumin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Plasma Albumin Sales by Application (2021-2026) & (K Units) Table 52. Global Plasma Albumin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Plasma Albumin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Plasma Albumin Sales Market Share in Value by Application (2021-2026) Table 55. Global Plasma Albumin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Plasma Albumin Sales by Application (2027-2032) & (K Units) Table 57. Global Plasma Albumin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Plasma Albumin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Plasma Albumin Sales Market Share in Value by Application (2027-2032) Table 60. Global Plasma Albumin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Plasma Albumin Sales by Application (2021-2026) & (K Units) Table 62. North America Plasma Albumin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Plasma Albumin Sales by Application (2021-2026) & (K Units) Table 64. Europe Plasma Albumin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Plasma Albumin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Plasma Albumin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Plasma Albumin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Plasma Albumin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Plasma Albumin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Plasma Albumin Sales by Application (2021-2026) & (US$ Million) Table 71. Yuanda Shuyang Company Information Table 72. Yuanda Shuyang Business Overview Table 73. Yuanda Shuyang Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yuanda Shuyang Plasma Albumin Product Portfolio Table 75. Yuanda Shuyang Recent Development Table 76. Takeda Company Information Table 77. Takeda Business Overview Table 78. Takeda Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Takeda Plasma Albumin Product Portfolio Table 80. Takeda Recent Development Table 81. Weiguang Bio Company Information Table 82. Weiguang Bio Business Overview Table 83. Weiguang Bio Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Weiguang Bio Plasma Albumin Product Portfolio Table 85. Weiguang Bio Recent Development Table 86. Tiantan Bio Company Information Table 87. Tiantan Bio Business Overview Table 88. Tiantan Bio Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Tiantan Bio Plasma Albumin Product Portfolio Table 90. Tiantan Bio Recent Development Table 91. Shanghai RAAS Company Information Table 92. Shanghai RAAS Business Overview Table 93. Shanghai RAAS Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shanghai RAAS Plasma Albumin Product Portfolio Table 95. Shanghai RAAS Recent Development Table 96. Hualan Bio Company Information Table 97. Hualan Bio Business Overview Table 98. Hualan Bio Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hualan Bio Plasma Albumin Product Portfolio Table 100. Hualan Bio Recent Development Table 101. Shuanglin Bio Company Information Table 102. Shuanglin Bio Business Overview Table 103. Shuanglin Bio Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shuanglin Bio Plasma Albumin Product Portfolio Table 105. Shuanglin Bio Recent Development Table 106. Octapharma Company Information Table 107. Octapharma Business Overview Table 108. Octapharma Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Octapharma Plasma Albumin Product Portfolio Table 110. Octapharma Recent Development Table 111. LFB Group Company Information Table 112. LFB Group Business Overview Table 113. LFB Group Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. LFB Group Plasma Albumin Product Portfolio Table 115. LFB Group Recent Development Table 116. Kedrion Company Information Table 117. Kedrion Business Overview Table 118. Kedrion Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Kedrion Plasma Albumin Product Portfolio Table 120. Kedrion Recent Development Table 121. Grifols Company Information Table 122. Grifols Business Overview Table 123. Grifols Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Grifols Plasma Albumin Product Portfolio Table 125. Grifols Recent Development Table 126. CSL Company Information Table 127. CSL Business Overview Table 128. CSL Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. CSL Plasma Albumin Product Portfolio Table 130. CSL Recent Development Table 131. CBPO Company Information Table 132. CBPO Business Overview Table 133. CBPO Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. CBPO Plasma Albumin Product Portfolio Table 135. CBPO Recent Development Table 136. Boya Bio Company Information Table 137. Boya Bio Business Overview Table 138. Boya Bio Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Boya Bio Plasma Albumin Product Portfolio Table 140. Boya Bio Recent Development Table 141. Biotest Company Information Table 142. Biotest Business Overview Table 143. Biotest Plasma Albumin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Biotest Plasma Albumin Product Portfolio Table 145. Biotest Recent Development Table 146. North America Plasma Albumin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. North America Plasma Albumin Sales by Country (2021-2026) & (K Units) Table 148. North America Plasma Albumin Sales Market Share by Country (2021-2026) Table 149. North America Plasma Albumin Sales Forecast by Country (2027-2032) & (K Units) Table 150. North America Plasma Albumin Sales Market Share Forecast by Country (2027-2032) Table 151. North America Plasma Albumin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Plasma Albumin Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Plasma Albumin Market Share by Country (2021-2026) Table 154. North America Plasma Albumin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Plasma Albumin Market Share Forecast by Country (2027-2032) Table 156. Europe Plasma Albumin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Europe Plasma Albumin Sales by Country (2021-2026) & (K Units) Table 158. Europe Plasma Albumin Sales Market Share by Country (2021-2026) Table 159. Europe Plasma Albumin Sales Forecast by Country (2027-2032) & (K Units) Table 160. Europe Plasma Albumin Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Plasma Albumin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Plasma Albumin Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Plasma Albumin Market Share by Country (2021-2026) Table 164. Europe Plasma Albumin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Plasma Albumin Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Plasma Albumin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Plasma Albumin Sales by Country (2021-2026) & (K Units) Table 168. Asia-Pacific Plasma Albumin Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Plasma Albumin Sales Forecast by Country (2027-2032) & (K Units) Table 170. Asia-Pacific Plasma Albumin Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Plasma Albumin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Plasma Albumin Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Plasma Albumin Market Share by Country (2021-2026) Table 174. Asia-Pacific Plasma Albumin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Plasma Albumin Market Share Forecast by Country (2027-2032) Table 176. Latin America Plasma Albumin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Latin America Plasma Albumin Sales by Country (2021-2026) & (K Units) Table 178. Latin America Plasma Albumin Sales Market Share by Country (2021-2026) Table 179. Latin America Plasma Albumin Sales Forecast by Country (2027-2032) & (K Units) Table 180. Latin America Plasma Albumin Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Plasma Albumin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Plasma Albumin Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Plasma Albumin Market Share by Country (2021-2026) Table 184. Latin America Plasma Albumin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Plasma Albumin Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Plasma Albumin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Plasma Albumin Sales by Country (2021-2026) & (K Units) Table 188. Middle East and Africa Plasma Albumin Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Plasma Albumin Sales Forecast by Country (2027-2032) & (K Units) Table 190. Middle East and Africa Plasma Albumin Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Plasma Albumin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Plasma Albumin Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Plasma Albumin Market Share by Country (2021-2026) Table 194. Middle East and Africa Plasma Albumin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Plasma Albumin Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Plasma Albumin Distributors List Table 199. Plasma Albumin Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Plasma Albumin Image Figure 2. Global Plasma Albumin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Albumin Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Albumin Sales (2021-2032) & (K Units) Figure 5. 20-25% Concentrations Image Figure 6. Global 20-25% Concentrations Sales YoY Growth (2021-2032) & (K Units) Figure 7. 5% Concentrations Image Figure 8. Global 5% Concentrations Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Plasma Albumin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Plasma Albumin Market Share by Type 2025 VS 2032 Figure 11. North America Plasma Albumin Sales Market Share in Volume by Type in 2025 Figure 12. North America Plasma Albumin Sales Market Share in Value by Type in 2025 Figure 13. Europe Plasma Albumin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Plasma Albumin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Plasma Albumin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Plasma Albumin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Plasma Albumin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Plasma Albumin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Plasma Albumin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Plasma Albumin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Plasma Albumin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Therapeutics Image Figure 24. Global Therapeutics Sales YoY Growth (2021-2032) & (K Units) Figure 25. Excipient Image Figure 26. Global Excipient Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Plasma Albumin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Plasma Albumin Market Share by Application 2025 VS 2032 Figure 31. North America Plasma Albumin Sales Market Share in Volume by Application in 2025 Figure 32. North America Plasma Albumin Sales Market Share in Value by Application in 2025 Figure 33. Europe Plasma Albumin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Plasma Albumin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Plasma Albumin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Plasma Albumin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Plasma Albumin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Plasma Albumin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Plasma Albumin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Plasma Albumin Sales Market Share in Value by Application in 2025 Figure 41. North America Plasma Albumin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Plasma Albumin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Plasma Albumin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Plasma Albumin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Plasma Albumin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Plasma Albumin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Plasma Albumin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Plasma Albumin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Plasma Albumin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Plasma Albumin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Plasma Albumin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Plasma Albumin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Plasma Albumin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Plasma Albumin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Plasma Albumin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Plasma Albumin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Plasma Albumin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 20-25% Concentrations
  • 5% Concentrations
Applications
  • Therapeutics
  • Excipient
  • Other
Companies covered
  • Yuanda Shuyang
  • Takeda
  • Weiguang Bio
  • Tiantan Bio
  • Shanghai RAAS
  • Hualan Bio
  • Shuanglin Bio
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • CBPO
  • Boya Bio
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plasma Albumin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Plasma Albumin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Plasma Albumin Market by Type
  6. 1.3.1 20-25% Concentrations
  7. 1.3.2 5% Concentrations
  8. 1.4 Global Plasma Albumin Market Size by Type
  9. 1.4.1 Global Plasma Albumin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Plasma Albumin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Plasma Albumin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Plasma Albumin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Plasma Albumin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Plasma Albumin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Plasma Albumin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Plasma Albumin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Plasma Albumin Industry Trends
  2. 2.2 Plasma Albumin Industry Drivers
  3. 2.3 Plasma Albumin Industry Opportunities and Challenges
  4. 2.4 Plasma Albumin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Plasma Albumin Revenue (2021-2026)
  2. 3.2 Global Top Players by Plasma Albumin Sales (2021-2026)
  3. 3.3 Global Top Players by Plasma Albumin Price (2021-2026)
  4. 3.4 Global Plasma Albumin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Plasma Albumin Major Company Production Sites & Headquarters
  6. 3.6 Global Plasma Albumin Company, Product Type & Application
  7. 3.7 Global Plasma Albumin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Plasma Albumin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Plasma Albumin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Plasma Albumin Tier 1, Tier 2, and Tier 3
4 Plasma Albumin Regional Status and Outlook
  1. 4.1 Global Plasma Albumin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Plasma Albumin Historic Market Size by Region
  3. 4.2.1 Global Plasma Albumin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Plasma Albumin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Plasma Albumin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Plasma Albumin Forecasted Market Size by Region
  7. 4.3.1 Global Plasma Albumin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Plasma Albumin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Plasma Albumin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Plasma Albumin by Application
  1. 5.1 Plasma Albumin Market by Application
  2. 5.1.1 Therapeutics
  3. 5.1.2 Excipient
  4. 5.1.3 Other
  5. 5.2 Global Plasma Albumin Market Size by Application
  6. 5.2.1 Global Plasma Albumin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Plasma Albumin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Plasma Albumin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Plasma Albumin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Plasma Albumin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Plasma Albumin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Plasma Albumin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Plasma Albumin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yuanda Shuyang
  2. 6.1.1 Yuanda Shuyang Company Information
  3. 6.1.2 Yuanda Shuyang Business Overview
  4. 6.1.3 Yuanda Shuyang Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yuanda Shuyang Plasma Albumin Product Portfolio
  6. 6.1.5 Yuanda Shuyang Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Plasma Albumin Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Weiguang Bio
  14. 6.3.1 Weiguang Bio Company Information
  15. 6.3.2 Weiguang Bio Business Overview
  16. 6.3.3 Weiguang Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Weiguang Bio Plasma Albumin Product Portfolio
  18. 6.3.5 Weiguang Bio Recent Developments
  19. 6.4 Tiantan Bio
  20. 6.4.1 Tiantan Bio Company Information
  21. 6.4.2 Tiantan Bio Business Overview
  22. 6.4.3 Tiantan Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tiantan Bio Plasma Albumin Product Portfolio
  24. 6.4.5 Tiantan Bio Recent Developments
  25. 6.5 Shanghai RAAS
  26. 6.5.1 Shanghai RAAS Company Information
  27. 6.5.2 Shanghai RAAS Business Overview
  28. 6.5.3 Shanghai RAAS Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai RAAS Plasma Albumin Product Portfolio
  30. 6.5.5 Shanghai RAAS Recent Developments
  31. 6.6 Hualan Bio
  32. 6.6.1 Hualan Bio Company Information
  33. 6.6.2 Hualan Bio Business Overview
  34. 6.6.3 Hualan Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hualan Bio Plasma Albumin Product Portfolio
  36. 6.6.5 Hualan Bio Recent Developments
  37. 6.7 Shuanglin Bio
  38. 6.7.1 Shuanglin Bio Company Information
  39. 6.7.2 Shuanglin Bio Business Overview
  40. 6.7.3 Shuanglin Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shuanglin Bio Plasma Albumin Product Portfolio
  42. 6.7.5 Shuanglin Bio Recent Developments
  43. 6.8 Octapharma
  44. 6.8.1 Octapharma Company Information
  45. 6.8.2 Octapharma Business Overview
  46. 6.8.3 Octapharma Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Octapharma Plasma Albumin Product Portfolio
  48. 6.8.5 Octapharma Recent Developments
  49. 6.9 LFB Group
  50. 6.9.1 LFB Group Company Information
  51. 6.9.2 LFB Group Business Overview
  52. 6.9.3 LFB Group Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 LFB Group Plasma Albumin Product Portfolio
  54. 6.9.5 LFB Group Recent Developments
  55. 6.10 Kedrion
  56. 6.10.1 Kedrion Company Information
  57. 6.10.2 Kedrion Business Overview
  58. 6.10.3 Kedrion Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Kedrion Plasma Albumin Product Portfolio
  60. 6.10.5 Kedrion Recent Developments
  61. 6.11 Grifols
  62. 6.11.1 Grifols Company Information
  63. 6.11.2 Grifols Business Overview
  64. 6.11.3 Grifols Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Grifols Plasma Albumin Product Portfolio
  66. 6.11.5 Grifols Recent Developments
  67. 6.12 CSL
  68. 6.12.1 CSL Company Information
  69. 6.12.2 CSL Business Overview
  70. 6.12.3 CSL Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CSL Plasma Albumin Product Portfolio
  72. 6.12.5 CSL Recent Developments
  73. 6.13 CBPO
  74. 6.13.1 CBPO Company Information
  75. 6.13.2 CBPO Business Overview
  76. 6.13.3 CBPO Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 CBPO Plasma Albumin Product Portfolio
  78. 6.13.5 CBPO Recent Developments
  79. 6.14 Boya Bio
  80. 6.14.1 Boya Bio Company Information
  81. 6.14.2 Boya Bio Business Overview
  82. 6.14.3 Boya Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Boya Bio Plasma Albumin Product Portfolio
  84. 6.14.5 Boya Bio Recent Developments
  85. 6.15 Biotest
  86. 6.15.1 Biotest Company Information
  87. 6.15.2 Biotest Business Overview
  88. 6.15.3 Biotest Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Biotest Plasma Albumin Product Portfolio
  90. 6.15.5 Biotest Recent Developments
7 North America by Country
  1. 7.1 North America Plasma Albumin Sales by Country
  2. 7.1.1 North America Plasma Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Plasma Albumin Sales by Country (2021-2026)
  4. 7.1.3 North America Plasma Albumin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Plasma Albumin Market Size by Country
  6. 7.2.1 North America Plasma Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Plasma Albumin Market Size by Country (2021-2026)
  8. 7.2.3 North America Plasma Albumin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Plasma Albumin Sales by Country
  2. 8.1.1 Europe Plasma Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Plasma Albumin Sales by Country (2021-2026)
  4. 8.1.3 Europe Plasma Albumin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Plasma Albumin Market Size by Country
  6. 8.2.1 Europe Plasma Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Plasma Albumin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Plasma Albumin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Plasma Albumin Sales by Country
  2. 9.1.1 Asia-Pacific Plasma Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Plasma Albumin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Plasma Albumin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Plasma Albumin Market Size by Country
  6. 9.2.1 Asia-Pacific Plasma Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Plasma Albumin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Plasma Albumin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Plasma Albumin Sales by Country
  2. 10.1.1 South America Plasma Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Plasma Albumin Sales by Country (2021-2026)
  4. 10.1.3 South America Plasma Albumin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Plasma Albumin Market Size by Country
  6. 10.2.1 South America Plasma Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Plasma Albumin Market Size by Country (2021-2026)
  8. 10.2.3 South America Plasma Albumin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Plasma Albumin Sales by Country
  2. 11.1.1 Middle East and Africa Plasma Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Plasma Albumin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Plasma Albumin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Plasma Albumin Market Size by Country
  6. 11.2.1 Middle East and Africa Plasma Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Plasma Albumin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Plasma Albumin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Plasma Albumin Value Chain Analysis
  2. 12.1.1 Plasma Albumin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Plasma Albumin Production Mode & Process
  7. 12.2 Plasma Albumin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Plasma Albumin Distributors
  10. 12.2.3 Plasma Albumin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst